A RANDOMIZED, MULTICENTER, DOUBLE BLIND, PHASE III STUDY OF ADJUVANT NIVOLUMAB OR PLACEBO IN SUBJECTS WITH RESECTED LOWER ESOPHAGEAL, OR GASTROESOPHAGEAL JUNCTION CANCER.
SAFETY AND EFFICACY OF A LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTIN IDIOPATHIC PULMONARY FIBROSISA MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF THE SAFETY ANDEFFICACY OF BMS-986020 IN SUBJECTS WITH IDIOPATHIC PULMONARY FIBROSIS
RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC COMPARATIVE STUDY, PHASE III, WITH TWO COURSES OF DIFFERENT THERAPY WITH BMS-284756 ORAL VS AMOXICILLINE / ORAL CLAVULANATE IN THE TREATMENT OF ACUTE SINUSITIS
100 项与 Bristol-Myers Squibb Peru SA 相关的临床结果
0 项与 Bristol-Myers Squibb Peru SA 相关的专利（医药）
100 项与 Bristol-Myers Squibb Peru SA 相关的药物交易
100 项与 Bristol-Myers Squibb Peru SA 相关的转化医学
